Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The company has received the GMP Certification after successful closure of the inspection
The trademark rights for these brands will be transferred to Lupin by March next year.
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Subscribe To Our Newsletter & Stay Updated
